Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Join | Sign in
Home>News

  News Archive

Aprea Granted European Orphan Drug Designation for APR-246 in Ovarian Cancer
Saturday, January 24, 2015
Company is currently conducting a Phase Ib/II trial of APR-246.

Dilaforette Receives Positive COMP Opinion
Thursday, January 22, 2015
Positive opinion on orphan drug designation in the EU for sevuparin in sickle-cell disease.

AMRI Receives NIH Contract Award
Wednesday, January 21, 2015
10-year federal contract award valued at up to $37 million.

Novogen Announces Important Discovery in Regenerative Medicine Program
Saturday, January 17, 2015
A key proof-of-concept step to develop drugs capable of stimulating the function of brain tissue stem cells.

ThromboGenics Appoints Dominique Vanfleteren as New CFO
Saturday, January 17, 2015
Dominique has over 25 years of experience in senior finance, operational, control and reporting roles.

BEYOND RESEARCH Initiative of 4SC Discovery and CRELUX Reaches First Milestone
Tuesday, January 13, 2015
Compounds for inhibiting oxygen radicals and associated signalling pathways optimized for developing innovative therapies for degenerative diseases.

Evotec and Padlock Therapeutics Extend Collaboration
Friday, January 09, 2015
Evotec and Padlock Therapeutics announce initial success and extension of long-term collaboration.

AMRI To Acquire Aptuit Drug Product Development Businesses
Friday, January 09, 2015
Significantly expands AMRI's analytical services capabilities and extends drug product development services to include sterile injectable formulation development.

Oncodesign Enters into a Services Agreement with Eisai
Friday, December 26, 2014
The program aims to identify useful patient stratification biomarkers for Eisai’s Halaven® eribulin using patient-derived xenograft models.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 4046
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters